Preference for Immunotherapy with Tablets by People with Allergic Rhinitis

References

• Seidman MD, Gurgel RK, Lin SY, et al. Clinical practice guideline: allergic rhinitis. Otolaryngol Neck Surg. 2015;152(2):197–206. doi:10.1177/0194599814561600
   PubMed Web of Science ®Google Scholar
• Cingi C, Gevaert P, Mösges R, et al. Multi-morbidities of allergic rhinitis in adults: European Academy of Allergy and Clinical Immunology Task Force Report. Clin Transl Allergy. 2017;7(1):17. doi:10.1186/s13601-017-0153-z
   PubMed Web of Science ®Google Scholar
• Scadding GK, Kariyawasam HH, Scadding G, et al. BSACI guideline for the diagnosis and management of allergic and non-allergic rhinitis (Revised Edition 2017; First edition 2007). Clin Exp Allergy. 2017;47(7):856–889. doi:10.1111/cea.12953
   PubMed Web of Science ®Google Scholar
• Bousquet J, Khaltaev N, Cruz AA, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008*: ARIA: 2008 Update. Allergy. 2008;63:8–160. doi:10.1111/j.1398-9995.2007.01620.x
   PubMed Web of Science ®Google Scholar
• Meltzer EO, Blaiss MS, Derebery MJ, et al. Burden of allergic rhinitis: results from the Pediatric Allergies in America survey. J Allergy Clin Immunol. 2009;124(3):S43–S70. doi:10.1016/j.jaci.2009.05.013
   PubMed Web of Science ®Google Scholar
• Institute for Clinical Systems Improvement. Guideline: non-Infectious Rhinitis - Treatment for Allergic Rhinitis. Available from: https://www.icsi.org/guideline/respiratory-illness/non-infectious-rhinitis-treatment-for-allergic-rhinitis/. Accessed January 25, 2021.
   Google Scholar
• Cox L, Nelson H, Lockey R, et al. Allergen immunotherapy: a practice parameter third update. J Allergy Clin Immunol. 2011;127(1):S1–S55. doi:10.1016/j.jaci.2010.09.034
   PubMed Web of Science ®Google Scholar
• Canonica GW, Durham SR Allergen Immunotherapy for allergic rhinitis and asthma: a Synopsis; 2016. Available from: https://www.worldallergy.org/education-and-programs/education/allergic-disease-resource-center/professionals/allergen-immunotherapy-a-synopsis. Accessed November 13, 2020.
   Google Scholar
• AAAAI. American Academy of Allergy Asthma & Immunology; 2020. Available from: https://www.aaaai.org. Accessed November 12, 2020.
   Google Scholar
• Durham SR, Emminger W, Kapp A, et al. SQ-standardized sublingual grass immunotherapy: confirmation of disease modification 2 years after 3 years of treatment in a randomized trial. J Allergy Clin Immunol. 2012;129(3):717–725.e5. doi:10.1016/j.jaci.2011.12.973
   PubMed Web of Science ®Google Scholar
• Bachert C, Larché M, Bonini S, et al. Allergen immunotherapy on the way to product-based evaluation—a WAO statement. World Allergy Organ J. 2015;8:29. doi:10.1186/s40413-015-0078-8
   PubMed Web of Science ®Google Scholar
• Jutel M, Akdis CA. Immunological mechanisms of allergen-specific immunotherapy. Allergy. 2011;66(6):725–732. doi:10.1111/j.1398-9995.2011.02589.x
   PubMed Web of Science ®Google Scholar
• Bernstein DI, Bardelas JA, Svanholm Fogh B, Kaur A, Li Z, Nolte H. A practical guide to the sublingual immunotherapy tablet adverse event profile: implications for clinical practice. Postgrad Med. 2017;129(6):590–597. doi:10.1080/00325481.2017.1302306
   PubMed Web of Science ®Google Scholar
• United Healthcare. Sublingual Immunotherapy.; 2020. Available from: https://www.uhcprovider.com/content/dam/provider/docs/public/policies/comm-medical-drug/sublingual-liquid-immunotherapy.pdf. Accessed February 19, 2021.
   Google Scholar
• U.S. Food and Drug Administration. Allergenics; 2021. Available from: https://www.fda.gov/vaccines-blood-biologics/allergenics. Accessed February 19, 2021.
   Google Scholar
• Cox L, Calderon MA. Subcutaneous specific immunotherapy for seasonal allergic rhinitis: a review of treatment practices in the US and Europe. Curr Med Res Opin. 2010;26(12):2723–2733. doi:10.1185/03007995.2010.528647
   PubMed Web of Science ®Google Scholar
• Elliott J, Kelly SE, Johnston A, Skidmore B, Gomes T, Wells GA. Allergen immunotherapy for the treatment of allergic rhinitis and/or asthma: an umbrella review. CMAJ Open. 2017;5(2):E373–E385. doi:10.9778/cmajo.20160066
   PubMedGoogle Scholar
• Jutel M, Agache I, Bonini S, et al. International consensus on allergy immunotherapy. J Allergy Clin Immunol. 2015;136(3):556–568. doi:10.1016/j.jaci.2015.04.047
   PubMed Web of Science ®Google Scholar
• Tankersley M, Han JK, Nolte H. Clinical aspects of sublingual immunotherapy tablets and drops. Ann Allergy Asthma Immunol. 2020;124(6):573–582. doi:10.1016/j.anai.2019.12.025
   PubMed Web of Science ®Google Scholar
• U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation and Research (CBER). Patient-Focused Drug Development: collecting Comprehensive and Representative Input (Guidance for Industry, Food and Drug Administration Staff, and Other Stakeholders); 2020. Available from: https://www.fda.gov/media/139088/download. Accessed February 8, 2021.
   Google Scholar
• Brazier JE, Dixon S, Ratcliffe J. The Role of Patient Preferences in Cost-Effectiveness Analysis: a Conflict of Values? PharmacoEconomics. 2009;27(9):705–712. doi:10.2165/11314840-000000000-00000
   PubMed Web of Science ®Google Scholar
• Chester JG, Bremberg MG, Reisacher WR. Patient preferences for route of allergy immunotherapy: a comparison of four delivery methods: patient preference for allergy immunotherapy. Int Forum Allergy Rhinol. 2016;6(5):454–459. doi:10.1002/alr.21707
   Web of Science ®Google Scholar
• Damm K, Volk J, Horn A, et al. Patient preferences in allergy immunotherapy (AIT) in Germany – a discrete-choice-experiment. Health Econ Rev. 2016;6(1):32. doi:10.1186/s13561-016-0110-x
   Web of Science ®Google Scholar
• Sivam A, Tankersley M. Perception and practice of sublingual immunotherapy among practicing allergists in the United States. Ann Allergy Asthma Immunol. 2019;122(6):623–629.e2. doi:10.1016/j.anai.2019.03.023
   PubMed Web of Science ®Google Scholar
• Bridges JFP, Hauber AB, Marshall D, et al. Conjoint Analysis Applications in Health—a Checklist: a Report of the ISPOR Good Research Practices for Conjoint Analysis Task Force. Value Health. 2011;14(4):403–413. doi:10.1016/j.jval.2010.11.013
   PubMed Web of Science ®Google Scholar
• Ryan M. Using conjoint analysis to elicit preferences for health care. BMJ. 2000;320(7248):1530–1533. doi:10.1136/bmj.320.7248.1530
   PubMed Web of Science ®Google Scholar
• Reed Johnson F, Lancsar E, Marshall D, et al. Constructing Experimental Designs for Discrete-Choice Experiments: report of the ISPOR Conjoint Analysis Experimental Design Good Research Practices Task Force. Value Health. 2013;16(1):3–13. doi:10.1016/j.jval.2012.08.2223
   PubMed Web of Science ®Google Scholar
• Federal Drug Administration. Patient Preference Information: voluntary Submission, Review in Premarket Approval Applications, Humanitarian Device Exemption Applications, and de Novo Requests, and Inclusion in Decision Summaries and Device Labeling Guidance for Industry, Food and Drug Administration Staff, and Other Stakeholders; 2016. Available from: https://www.fda.gov/media/92593/download. Accessed January 29, 2021.
   Google Scholar
• Dahl R, Roberts G, de Blic J, et al. SQ grass sublingual allergy immunotherapy tablet for disease-modifying treatment of grass pollen allergic rhinoconjunctivitis. Allergy Asthma Proc. 2016;37(2):92–104. doi:10.2500/aap.2016.37.3937
   Web of Science ®Google Scholar
• The Kaiser Family Foundation. Employer Health Benefits Survey 2018 (Annual Survey); 2018. Available from: http://files.kff.org/attachment/Report-Employer-Health-Benefits-Annual-Survey-2018. Accessed March 9, 2021.
   Google Scholar
• Ibrahim SA. Patient Preference as a Barrier to Needed Care. Am J Public Health. 2015;105(4):613–614. doi:10.2105/AJPH.2015.302603
   Web of Science ®Google Scholar
• Maloney J, Berman G, Gagnon R, et al. Sequential Treatment Initiation with Timothy Grass and Ragweed Sublingual Immunotherapy Tablets Followed by Simultaneous Treatment Is Well Tolerated. J Allergy Clin Immunol Pract. 2016;4(2):301–309.e2. doi:10.1016/j.jaip.2015.11.004
   PubMed Web of Science ®Google Scholar
• Blaiss MS, Steven GC, Bender B, Bukstein DA, Meltzer EO, Winders T. Shared decision making for the allergist. Ann Allergy Asthma Immunol. 2019;122(5):463–470. doi:10.1016/j.anai.2018.08.019
   PubMed Web of Science ®Google Scholar
• Field K, Blaiss MS. Sublingual Versus Subcutaneous Immunotherapy for Allergic Rhinitis: what Are the Important Therapeutic and Real-World Considerations? Curr Allergy Asthma Rep. 2020;20(9):45. doi:10.1007/s11882-020-00934-4
   Web of Science ®Google Scholar
• Winders T, DuBuske L, Bukstein DA, Meltzer EO, Wallace D, Rance K. Shifts in allergy practice in a COVID-19 world: implications of pre–COVID-19 national health care provider and patient surveys of treatments for nasal allergies. Allergy Asthma Proc. 2021;42(4):301–309. doi:10.2500/aap.2021.42.210035
   Web of Science ®Google Scholar
• Arbes Jr. SJ, Gergen PJ, Elliott L, Zeldin DC. Prevalences of positive skin test responses to 10 common allergens in the US population: results from the Third National Health and Nutrition Examination Survey. J Allergy Clin Immunol. 2005;116(2):377–383. doi:10.1016/j.jaci.2005.05.017
   Web of Science ®Google Scholar
• Cox L, Jacobsen L. Comparison of allergen immunotherapy practice patterns in the United States and Europe. Ann Allergy Asthma Immunol. 2009;103(6):451–460. doi:10.1016/S1081-1206(10)60259-1
   PubMed Web of Science ®Google Scholar
• Marogna M, Spadolini I, Massolo A, et al. Effects of sublingual immunotherapy for multiple or single allergens in polysensitized patients. Ann Allergy Asthma Immunol. 2007;98(3):274–280. doi:10.1016/S1081-1206(10)60718-1
   PubMed Web of Science ®Google Scholar
• Varney VA, Edwards J, Tabbah K, Brewster H, Mavroleon G, Frew AJ. Clinical efficacy of specific immunotherapy to cat dander: a double-blind placebo-controlled trial. Clin Exp Allergy. 1997;27(8):860–867. doi:10.1111/j.1365-2222.1997.tb01225.x
   PubMed Web of Science ®Google Scholar